Evidence-Based Management of Cardiovascular Risk in the OR

Evidence-based management of cardiovascular risk in the operating room (OR) is a critical component of protecting patient safety and improving surgical outcomes. Perioperative cardiovascular complications, including myocardial infarction, arrhythmias, heart failure, and stroke, contribute substantially to postoperative morbidity and mortality. As surgical populations age and comorbid disease burden increases, perioperative risk stratification and targeted optimization strategies have become increasingly important. Contemporary management emphasizes guideline-directed evaluation, individualized hemodynamic goals, and prevention of avoidable physiologic stress.

Evidence-based management begins with a preoperative cardiovascular assessment to identify patient-specific and procedure-specific risk factors. Major predictors of perioperative cardiac complications include ischemic heart disease, heart failure, cerebrovascular disease, diabetes mellitus requiring insulin, renal dysfunction, and poor functional status. Risk indices such as the Revised Cardiac Risk Index (RCRI) assist clinicians in estimating perioperative major adverse cardiac events. Current guidelines emphasize that preoperative testing should only be pursued if results are expected to alter management. Routine stress testing in asymptomatic patients undergoing low-risk surgery has not demonstrated improved outcomes and may unnecessarily delay care. 

Functional capacity remains one of the strongest predictors of perioperative cardiac tolerance. Patients capable of performing greater than 4 metabolic equivalents of activity without symptoms generally tolerate noncardiac surgery. Conversely, poor exercise tolerance may indicate limited cardiovascular reserve and increased perioperative risk. Biomarkers such as B-type natriuretic peptide (BNP) and cardiac troponins are also valuable adjuncts for identifying high-risk patients, particularly among elderly individuals and those undergoing major vascular procedures. 

Intraoperative management focuses on maintaining physiologic stability while minimizing myocardial oxygen supply-demand imbalance. Hemodynamic fluctuations, especially prolonged hypotension and tachycardia, are associated with perioperative myocardial injury. Increasing evidence suggests that even brief episodes of mean arterial pressure below critical thresholds may contribute to renal and cardiac complications. Goal-directed fluid therapy and individualized blood pressure management have therefore become important components of cardiovascular risk reduction. 

Beta-blocker therapy is one of the most studied perioperative interventions. Continuation of chronic beta-blockade is strongly recommended because abrupt withdrawal may precipitate ischemia or arrhythmias. However, initiation of high-dose beta-blockers immediately before surgery has been associated with increased stroke and mortality risk despite reducing myocardial infarction incidence. Based on current evidence, beta-blocker therapy may be initiated preoperatively only in certain patients and preferably well in advance of surgery to allow dose titration and stabilization of cardiovascular status prior to entering the OR. 

Management of antiplatelet and anticoagulant therapy requires balancing thrombotic and bleeding risks. Patients with recent coronary stents present particular challenges. Premature discontinuation of dual antiplatelet therapy may lead to catastrophic stent thrombosis, whereas continuation may increase surgical bleeding. Multidisciplinary coordination among anesthesiologists, surgeons, and cardiologists is therefore essential. Elective procedures should ideally be delayed until recommended durations of antiplatelet therapy are completed. 

Postoperative surveillance is a critical component of cardiovascular risk management. Many perioperative myocardial infarctions occur without detectable chest pain due to postoperative analgesia. Postoperative troponin monitoring in high-risk patients may allow earlier detection of myocardial injury and prompt intervention. Enhanced recovery protocols emphasizing early mobilization, multimodal analgesia, and pulmonary optimization may further reduce cardiovascular complications by limiting physiologic stress responses. 

Evidence-based perioperative cardiovascular management continues to evolve toward precision medicine and individualized care pathways. Contemporary practice integrates validated risk assessment tools, guideline-directed medical therapy, vigilant hemodynamic control, and multidisciplinary coordination to reduce perioperative morbidity and mortality. Ongoing research into biomarkers, artificial intelligence risk prediction, and perioperative monitoring technologies may further refine cardiovascular management strategies in the operating room. 

References 

1. Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2024 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation. 2024;150(12):e278-e366. https://doi.org/10.1161/CIR.0000000000001285 
2. Devereaux PJ, Sessler DI. Cardiac complications in patients undergoing major noncardiac surgery. N Engl J Med.2015;373(23):2258-2269. 10.1056/NEJMra1502824 
3. Biccard BM, Rodseth RN. A meta-analysis of the prospective randomised trials of beta-blockade for prevention of perioperative cardiac complications in non-cardiac surgery. Anaesthesia. 2008;63(1):4-16. 10.1111/j.1365-2044.2009.06010.x 
4. Wijeysundera DN, Beattie WS, Austin PC, Hux JE, Laupacis A. Non-invasive cardiac stress testing before elective major non-cardiac surgery: population based cohort study. BMJ. 2010;340:b5526. 10.1136/bmj.b5526 
5. Sessler DI, Meyhoff CS, Zimmerman NM, et al. Period-dependent associations between hypotension during and for four days after noncardiac surgery and a composite of myocardial infarction and death. Anesthesiology.2018;128(2):317-327. 10.1097/ALN.0000000000001985